Bioasis Technologies Inc.
BIOAF
$0.00
$0.00-66.67%
OTC PK
| 11/30/2022 | 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 203.90K | 123.40K | 30.00K | 30.00K | 30.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 203.90K | 123.40K | 30.00K | 30.00K | 30.00K |
| Cost of Revenue | 607.10K | 683.60K | 817.00K | 817.00K | 867.40K |
| Gross Profit | -403.20K | -560.10K | -786.90K | -786.90K | -837.30K |
| SG&A Expenses | 1.83M | 1.77M | 1.80M | 1.92M | 1.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.58M | 2.60M | 2.76M | 2.90M | 2.97M |
| Operating Income | -2.38M | -2.48M | -2.73M | -2.87M | -2.94M |
| Income Before Tax | -2.21M | -2.49M | -2.11M | -2.36M | -2.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.21 | -2.49 | -2.11 | -2.36 | -2.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.21M | -2.49M | -2.11M | -2.36M | -2.77M |
| EBIT | -2.38M | -2.48M | -2.73M | -2.87M | -2.94M |
| EBITDA | -2.31M | -2.42M | -2.69M | -2.83M | -2.90M |
| EPS Basic | -0.03 | -0.03 | -0.03 | -0.03 | -0.04 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.03 | -0.03 | -0.03 | -0.03 | -0.04 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 301.58M | 295.51M | 289.44M | 288.67M | 290.79M |
| Average Diluted Shares Outstanding | 301.58M | 295.51M | 289.44M | 288.67M | 290.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |